No immediate trading implications. Monitor for any pattern of ESOP exercises which could indicate employee sentiment, but this isolated event is immaterial to share value.
RDY drugs
RDY drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 26 $13.77entry
- T+1 · 8mo ago −2.11%α −0.43% · $13.48
- T+5 · 8mo ago −3.27%α −4.90% · $13.32
- T+20 · 7mo ago −0.73%α −11.39% · $13.67
- T+60 · 5mo ago +1.89%α −12.06% · $14.03
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Dr. Reddy's Laboratories issued 3,675 equity shares on March 26, 2026, following the exercise of stock options under its 2007 ESOP scheme. The shares were allotted at par value of Re.1 each, with 3,100 shares issued at an exercise price of Rs. 735.80 each.
Key Facts
- Company allotted 3,675 fully paid equity shares of Re.1 each on March 26, 2026
- Shares were issued pursuant to the Dr. Reddy's Employees ADR Stock Options Scheme, 2007
- 575 shares issued at Re.1 each, 3,100 shares issued at Rs. 735.80 each
- Total issued share capital increased to 83,46,57,970 shares
- Filing made under SEBI Listing Obligations & Disclosure Requirements Regulations, 2015
Financial Impact
Minimal financial impact - issuance of only 3,675 shares represents less than 0.005% of total outstanding shares
Risk Factors
- Minimal dilution effect from new share issuance
- Potential perception of insider selling if option holders immediately sell shares
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000166 |
| Document: 0001575872-26-000166-index.html | 0001575872-26-000166 |
| Document: 0001575872-26-000166.txt | 0001575872-26-000166 |
Track record
73 reports on RDY
7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.
Filters
- Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
- Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
- Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
- Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
- Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
- Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers